F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
13600.0 |
(mg/dl) x min |
327.27 |
1085.44 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
11468 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
14072.73 |
(mg/dl) x min |
363.64 |
1206.05 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
11469 |
85 |
SDT/Jcl |
blood glucose level area under curve (AUC) |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 5 |
8.3 |
(mg/dl) x min |
1.91 |
4.27 |
oral glucose tolerance test |
|
0.0 |
oral dose |
0 |
|
trapezoid rule used for calculation |
|
11604 |
106 |
DA/K |
blood glucose level area under curve (AUC) |
glucose solution (2 g/kg) |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood glucose amount |
female |
0 days
| 12 |
8636.36 |
(mg/dl) x min |
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
intraperitoneal injection |
60 |
min |
glucose analyser (Medingen ESAT 6660-2, Germany) |
samples taken at 0, 10, 30, 60 minutes |
13274 |
251 |
F344/DuCrlCrlj |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 15 |
15545.45 |
(mg/dl) x min |
381.82 |
1478.78 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
11446 |
85 |
F344/NSlc |
blood glucose level area under curve (AUC) |
specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) |
Fuse M, et al., Physiol Genomics. 2008 Jul 8;. |
blood glucose amount |
male |
420 days
| 7 |
1.8 |
(mg/dl) x min |
0.52 |
1.38 |
oral glucose tolerance test |
|
0 |
oral dose |
0 |
|
trapezoid rule used for calculation |
|
11606 |
106 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
18200.0 |
(mg/dl) x min |
509.09 |
1688.46 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
11448 |
85 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
17654.55 |
(mg/dl) x min |
636.36 |
2110.58 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
11447 |
85 |
F344/DuCrlCrlj |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 15 |
12818.18 |
(mg/dl) x min |
218.18 |
845.01 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
|
11467 |
85 |
WOKW/K |
blood glucose level area under curve (AUC) |
glucose solution (2 g/kg) |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood glucose amount |
not specified |
196 days-224 days |
12 |
11854.55 |
(mg/dl) x min |
456.63 |
1581.82 |
intraperitoneal glucose tolerance test |
|
0.0 |
IPGTT |
60 |
min |
|
|
96850 |
1123 |
WOKW |
blood glucose level area under curve (AUC) |
glucose solution (2 g/kg) |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood glucose amount |
female |
0 days
| 12 |
11127.27 |
(mg/dl) x min |
|
|
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
intraperitoneal injection |
60 |
min |
glucose analyser (Medingen ESAT 6660-2, Germany) |
samples taken at 0, 10, 30, 60 minutes |
13272 |
251 |
BN/Seac |
blood glucose level area under curve (AUC) |
fasting (for 18 hours) then glucose solution (2 g/kg) |
Masuyama T, et al., Biochem Biophys Res Commun 2003 Apr 25;304(1):196-206. |
blood glucose amount |
male |
140 days
| 0 |
17646.0 |
(mg/dl) x min |
510.0 |
|
oral glucose tolerance test |
|
0.0 |
oral dose |
120 |
min |
|
|
67911 |
833 |
SDT/Jcl |
blood glucose level area under curve (AUC) |
fasting (for 18 hours) then glucose solution (2 g/kg) |
Masuyama T, et al., Biochem Biophys Res Commun 2003 Apr 25;304(1):196-206. |
blood glucose amount |
male |
140 days
| 0 |
37998.0 |
(mg/dl) x min |
1584.0 |
|
oral glucose tolerance test |
|
0.0 |
oral dose |
120 |
min |
|
|
67912 |
833 |
DA/K |
blood glucose level area under curve (AUC) |
glucose solution (2 g/kg) |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood glucose amount |
not specified |
196 days-224 days |
12 |
8872.73 |
(mg/dl) x min |
335.91 |
1163.64 |
intraperitoneal glucose tolerance test |
|
0.0 |
IPGTT |
60 |
min |
|
|
96851 |
1123 |